1. Home
  2. BKSY vs SGP Comparison

BKSY vs SGP Comparison

Compare BKSY & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackSky Technology Inc.

BKSY

BlackSky Technology Inc.

N/A

Current Price

$20.82

Market Cap

839.0M

Sector

Technology

ML Signal

N/A

Logo SpyGlass Pharma Inc. Common Stock

SGP

SpyGlass Pharma Inc. Common Stock

N/A

Current Price

$24.58

Market Cap

799.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BKSY
SGP
Founded
2013
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
839.0M
799.4M
IPO Year
2019
2026

Fundamental Metrics

Financial Performance
Metric
BKSY
SGP
Price
$20.82
$24.58
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
6
Target Price
$38.42
★ $44.00
AVG Volume (30 Days)
★ 826.6K
108.2K
Earning Date
11-05-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 21.72
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$32.92
N/A
Revenue Next Year
$36.54
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.41
$17.06
52 Week High
$52.88
$30.56

Technical Indicators

Market Signals
Indicator
BKSY
SGP
Relative Strength Index (RSI) 41.83 43.98
Support Level $20.40 $25.00
Resistance Level $24.34 $26.29
Average True Range (ATR) 1.21 1.42
MACD 0.03 -0.41
Stochastic Oscillator 16.71 30.19

Price Performance

Historical Comparison
BKSY
SGP

About BKSY BlackSky Technology Inc.

BlackSky Technology Inc is a space-based technology company that delivers real-time imagery, analytics and high-frequency monitoring of the worlds critical and strategic locations, economic assets, and events. By taking a software-first technology approach, Company is delivering real-time space-based intelligence at disruptive speed, scale and economics. Companies single operating and reportable segment, provided space-based intelligence products and services through three integrated revenue streams-space-based intelligence & AI services, mission solutions, and technology programs. Geographically, the company operates in United States and Rest of world.

About SGP SpyGlass Pharma Inc. Common Stock

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Share on Social Networks: